September 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2017. This roundup includes...
Accurate Lung Cancer Staging Depends on Quality Nodal Exam
Difference in exam thoroughness may account for large regional differences in survival
Checkpoint Inhibitors No Less Safe With Radiation
Combination does not increase immune-related adverse events in metastatic lung cancer patients
Upper Abdominal Cancer Resections Up in Octogenarians
Increase in resection rates driven by trends in hepatic and pancreatic resections
Embezzlement Widespread in Medical Practices
Red flags include employee being secretive about their work, working late, not wanting to share tasks
Central Neck Dissection Underused in Some Thyroid CA
Risk of reoperation up with lymph node metastasis; reduced with central, lateral neck dissection
ASTRO: Patient Experience of Radiation Better Than Expected
Few breast cancer patients agree that negative stories they initially heard/read were actually true
ASTRO: SBRT Prolongs Survival in Non-Small-Cell Lung Cancer
Trial stopped after significant improvement in progression-free survival in metastatic NSCLC
ASTRO: Aggressive Reduction of Radiation Beneficial in OPSCC
In HPV-related disease, the approach linked to high cure rates, reduced side effects
More Than 78 Percent of Health Care Personnel Receive Flu Shot
But only 53.6 percent of pregnant women received flu shot before/during pregnancy in 2016-2017
